ServicenavigationHauptnavigationTrailKarteikarten

Research unit
SIAK
Project number
SAKK 35/98
Project title
A randomized phase III trial to determine the effect of consolidation with rituximab (IDEC C2B8 Mabthera) in patients with CD20+ follicular or mantle cell lymphoma having received induction therapy with rituximab weekly x 4

Participants

Research organisation: Swiss Institute for Applied
Cancer Research SIAK
Effingerstrasse 40
CH-3008 Bern
+41 (0)31 389 91 91 (Zentrale)
siakcc@sakk.ch
Contact person

 Ghielmini M
Swiss Institute for Applied
Cancer Research SIAK
Effingerstrasse 40
CH-3008 Bern
+41 (0)31 389 91 91 (Zentrale)
siakcc@sakk.ch